Home › Type 1 Diabetes › NCT07720388

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

Who can join

Ages 10 to 20 · All sexes

Inclusion Criteria:

* Age 10 - 20 years old
* Diagnosis of type 1 diabetes
* Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
* Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
* Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study

Exclusion Criteria:

* Current use of any Medtronic technology
* More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
* Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
* Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation
* Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

About the study

This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system.

The main question it aims to answer is:

Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes?

Participants will:

* Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members

What is being tested

• Culturally and linguistically tailored onboarding and support program (other)
• Medtronic MiniMed 780G Insulin Pump System (device)

Sponsor: University of Colorado, Denver · Participants: 15 · Started: Oct 2, 2026

Contact the study team

• Study Coordinator · Phone: 303-724-4315

Official record on ClinicalTrials.gov — NCT07720388

Locations in the U.S.

Conditions

• Type 1 Diabetes

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.